Adjustment Disorders Clinical Trial
Official title:
Work-focused Versus Generic Internet-based Interventions for Employees With Stress-related Disorders - a Randomized Controlled Trial
Verified date | February 2022 |
Source | Linkoeping University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Objective The aim of the current study was to evaluate the efficacy of an internet-based cognitive-behavioural intervention for stress-related disorders integrating work-related aspects (W-iCBT), compared with a generic iCBT and a waitlist control group (WLC). Method In this trial, 182 employees, mainly employed in the healthcare, IT or educational sector, who fulfilled the criteria for a stress-related disorder, were randomized to a 10-week W-iCBT (n=61), generic iCBT (n=61) or WLC (n=60). Self-rated questionnaires on perceived stress, burnout, exhaustion and other mental-health and work-related outcomes were administered pre- and post-treatment, and at a six- and 12-months follow-up. Results Compared to WLC, participants of the W-iCBT and iCBT showed equal and significant reduction on the primary outcome (SMBQ) from pre to post assessment (d=1.00 and 0.83 respectively) and at the six months follow-up (d=0.74 and 0.74). Significant moderate-to-large effect sizes were also found on the secondary health and work-related outcomes. The W-iCBT was the only group who exhibited significant effects on work ability and sickness absence. Sickness absence was 445 days (7.29 days per participant) lower compared to the WLC and 324 days (5.31 days per participant) compared to the iCBT intervention. However, no significant differences were found on work experience or long-term sick leave. Conclusion The work-focused and generic iCBT interventions proved to be superior and equally effective compared to the control condition in reducing chronic stress and several other mental health related symptoms. Interestingly, effects on work ability and sickness absence were only seen between the work-focused iCBT intervention and the WLC. These preliminary results are promising, as they provide further evidence that treatments that integrate work-aspects has great potential in accelerating both recovery and reduce sickness absence due to stress-related disorders.
Status | Completed |
Enrollment | 182 |
Est. completion date | August 26, 2019 |
Est. primary completion date | August 26, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: Participants were employees who had volunteered for the trial. To be eligible for the study, they had to fulfil the criteria for an adjustment disorder described in the subdivision F43 Reaction to severe stress, and adjustment disorders of the ICD-10. The diagnosis was established through telephone interviews using the Mini International Neuropsychiatric Interview, additional criteria from the International Statistical Classification of Diseases and Related Health Problems (ICD-10; 25), and national diagnostic guidelines regarding stress-related disorders. In addition to an adjustment disorder, participants had to fulfil the following criteria: (i) a minimum age of 18 years, (ii) mastering Swedish, (iii) have access to a computer or a tablet computer with internet-access, (iv) currently employed, (v) score of >1.5 points on the Shirom Melamed Burnout Questionnaire (SMBQ), <34 points on the Montgomery Åsberg Depression Scale-Self Rated (MADRS-S), <21 points on the Insomnia Severity Index (ISI) and <14 points on the Alcohol Use Disorders Identification Test (AUDIT). Mild to moderate forms of DSM axis-I diagnosis were accepted as co-morbid conditions, as long as these were considered to be secondary to the primary adjustment disorder. Participants' on full- or part-time sick leave, one year or less, were also included. Exclusion Criteria: Participants were excluded from the study if they (i) currently in treatment for stress-related disorder, (ii) currently were suffering from bipolar disorder, psychosis, post-traumatic stress disorder (PTSD), eating disorder, substance abuse, severe forms of depression, anxiety disorder or personality disorders, or (iv) were showing suicidal ideation based on item 9 of the MADRS-S. Participants on medication (e.g., antidepressants or sleep medication) were not excluded from the study but were requested to keep their medication constant during the study period. |
Country | Name | City | State |
---|---|---|---|
Sweden | Department of Behavioral Sciences and Learning, Linköping University | Linköping | Östergötland |
Lead Sponsor | Collaborator |
---|---|
Linkoeping University |
Sweden,
Eurofound. Sixth European Working Conditions Survey - Overview report (2017 update). Luxembourg: Publications Office of the European Union; 2017.
Sterling P, Eyer J. A new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handb Life Stress Cogn Health Oxford: John Wiley & Sons; 1988. p. xxxiii, 750.
World Health Organization. The global burden of disease : 2004 update. Geneva: World Health Organization; 2008.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Shirom-Melamed Burnout Questionnaire | The Shirom-Melamed Burnout Questionnaire (SMBQ; Melamed et al., 1992, 1999), is a 22-item scale (graded 1-7) used to assess different aspects of chronic stress and burnout (Physical Fatigue, Cognitive weariness, Tension, and Listlessness). This scale correlates signi?cantly [58] with other well established questionnaires measuring burnout, e.g., Maslach Burnout Inventory [59]. The SMBQ has an internal consistency reliability (Cronbach's alpha) of .92. [56]. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Perceived Stress Scale | Perceived stress was measured with the 10-item version of the Perceived Stress Scale (PSS-14), translated into Swedish [60,61]. The PSS-10 is designed to measure the degree to which situations in one's life are appraised as stressful. The Swedish version of PSS has an internal consistency reliability (Cronbach's alpha) of .82 and split-half reliability estimate of .84 [61]. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Karolinska Exhaustion Disorder Scale | Karolinska Exhaustion Disorder Scale (KEDS-9) is a 9-item questionnaire measuring symptoms of chronic stress, fatigue and exhaustion [62]. The instrument is answered on a 7-point scale, with a scale range of 0-54. A cut-off score of 19 was shown to discriminate between healthy subjects and patients with chronic stress and exhaustion [62]. KEDS-9 has satisfactory reliability, Cronbach's alpha of .94 [62]. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Montgomery Åsberg Depression Rating Scale | We used the Montgomery Åsberg Depression Rating Scale self-assessment, MADRS-S [63] to measure symptoms of depression. MADRS-S consists of nine items measuring different symptoms of depression and each symptom is rated on a six-point scale. The instrument has good reliability [64] and has been validated as an internet-based measure [65]. In a comparative study [66] the MADRS-S correlated highly (r = .87) with the Beck Depression Inventory [67], indicating acceptable convergent validity. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Generalised Anxiety Disorder Scale | Generalized Anxiety Disorder 7-item Scale (GAD-7) is an instrument assessing excessive worry and generalized anxiety disorder. GAD-7 had good internal consistency reliability (a = .83), test-retest reliability (r = .83), as well as criterion, construct, factorial, and procedural validity [68]. A cut-off score of 10 has been suggested to discriminates between healthy subjects and patients with generalized anxiety disorder. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Insomnia Severity Index | The Insomnia Severity Index (ISI) is a 7-item self-report questionnaire that measures individuals perceptions of their insomnia and the severity of problems with delayed sleep onset, sleep maintenance, and early morning awakenings [69]. ISI exhibits adequate internal consistency measures (a =.74), and is a sensitive measure to detect changes in perceived sleep difficulties [69]. It has previously been validated as an internet-based measure [70]. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Alcohol Use Disorders Identification Test | The Alcohol Use Disorders Identification Test (AUDIT; [71] was used to assess potential alcohol dependence or abuse. In a study of the psychometric properties of the Swedish version of AUDIT, both internal and test-retest reliabilities were satisfactory [72]. A cut-off of <14 points on the AUDIT indicating risk of overconsumption of alcohol [73]. | Change between baseline and end of treatment after ten weeks | |
Secondary | Work Experience Measurement Scale | The Work Experience Measurement Scale (WEMS) is an instrument measuring the experience of work from a health resource perspective [74]. WEMS consists of 32 items measuring job satisfaction in five different domains (supportive work conditions, internal work experience, autonomy, time experience, management, process of change) on a six-point scale. Cronbach's alpha on the WEMS has been reported to be in the interval of .85-.96 [74]. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Work Ability Index | Work Ability Index (WAI) is an instrument for assessing health status and work ability among employees [75-77]. The WAI comprises of different scales, with scores ranging from 7 to 49 points. Studies [75] have suggested that 7-27 points = poor; 28-36 points = moderate; 37-43 points = good; and 44-49 points indicates excellent work ability. Analyses of reliability indicates satisfactory internal consistency, a-levels ranging from .79 to .80 [78,79]. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Sheehan Disability Scale | Sheehan Disability Scale (SDS) measures quality of life and everyday function in three domains; Work ability, Social life and Family life. The instrument is answered on a 10-point VAS scale, with a scale range of 0-30. SDS has satisfactory internal consistency reliability (a = 0.89) and test-retest reliability (r = 0.73; 42,43). | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Recovery Experiences Questionnaire | The 16-item Recovery Experience Questionnaire (REQ) includes four factors, representing four different recovery experiences; (i) psychological detachment (ii) relaxation, (iii) mastery and (iv) control [82]. The questionnaire is answered on a 5-point Likert scale, and has been validated in a Swedish population showing excellent internal consistency, a=0.92 [83]. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment | |
Secondary | Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry | TiC-P has been used in several studies for economic evaluations of healthcare consumption and productivity loss in mental health [84]. Sickness absence were conceptualized as the self-rated number of days during the past three months absent from work while being physically or mentally ill. | Change between baseline and end of treatment after ten weeks and follow-up at 6 month and 1 year after treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01234961 -
Outcome Study of the ReDO Intervention for Women With Stress-related Disorders
|
N/A | |
Completed |
NCT02621775 -
Effectiveness of Two Stress Management Programs in Adaptation Disorder With Anxiety (ADA)
|
N/A | |
Recruiting |
NCT03358056 -
Effects of Mindfulness Based Cognitive Therapy on Emotional Processing
|
N/A | |
Recruiting |
NCT05584826 -
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
|
Phase 2 | |
Not yet recruiting |
NCT05455996 -
MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers
|
Phase 2 | |
Completed |
NCT05586789 -
A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders
|
Phase 3 | |
Completed |
NCT03360136 -
Open Clinical Trial of CBT-based Multiprofessional Rehabilitation for Exhaustion Disorder
|
N/A | |
Completed |
NCT00619411 -
Interpersonal Psychotherapy for Depressed Adolescents and Parents
|
Phase 1 | |
Recruiting |
NCT05464121 -
A Blended Intervention for Adjustment Disorder.
|
N/A | |
Completed |
NCT03151681 -
The Trauma of Betrayal: Treating Adjustment Disorder With Reconsolidation Blockade Under Propranolol
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05768308 -
Online CBT Intervention for Students With Adjustment Disorder
|
N/A | |
Recruiting |
NCT05963308 -
Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the HealthyMinds Online Group Intervention
|
N/A | |
Recruiting |
NCT03152175 -
Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators
|
Phase 2 | |
Active, not recruiting |
NCT04797273 -
Internet-based CBT vs. TAU for Stress-related Disorders
|
N/A | |
Not yet recruiting |
NCT03444740 -
Lower Urinary Tract Symptoms in Women and Adjustment Disorder
|
N/A | |
Active, not recruiting |
NCT01805583 -
Return to Work: Promoting Health and Productivity in Workers With Common Mental Disorders
|
N/A | |
Completed |
NCT04953338 -
Mental Health Associations With Vitiligo
|
||
Recruiting |
NCT04900064 -
Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial
|
N/A | |
Not yet recruiting |
NCT06433271 -
Transdiagnostic Behavior Therapy vs TAU for Adjustment Disorder Following Traumatic Event Exposure
|
N/A | |
Completed |
NCT05206734 -
Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health
|